ARTICLES BY MARCO LA VECCHIA
-
Roche And InterMune's Esbriet For IPF Approved By FDA10/20/2014
The U.S. Food and Drug Administration (FDA) announced its approval of Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF).